Suicide widow sues Pfizer over Chantix

It had to happen sometime: The widow of a man who committed suicide in January has sued Pfizer, alleging that the drugmaker should have warned Chantix patients sooner about its psychiatric side effects. Report

Suggested Articles

Alnylam is ready to follow on its Onpattro launch with an FDA nod for Givlaari. But the drug's safety profile is giving analysts reason to pause.

FDA nominee Stephen Hahn faced questions from Senators on Wednesday on topics including drug pricing, biosimilars, opioids and more.

BMS’ Opdivo-Yervoy combo been game-changing in late-stage melanoma. But when it comes to expanding the pair’s reach, the company has hit a roadblock.